Matera MG - Search Results

1

A single high dose of formoterol is as effective as the same dose administered in a cumulative manner in patients with acute exacerbation of COPD.

Cazzola M, Santus P, Matera MG, Carlucci P, Belloli E, Di Marco F, Centanni S. Cazzola M, et al. Among authors: matera mg. Respir Med. 2003 May;97(5):458-62. doi: 10.1053/rmed.2002.1456. Respir Med. 2003. PMID: 12735660 Free article. Clinical Trial.

2

Arformoterol tartrate in the treatment of COPD.

Cazzola M, Hanania NA, Matera MG. Cazzola M, et al. Among authors: matera mg. Expert Rev Respir Med. 2010 Apr;4(2):155-62. doi: 10.1586/ers.10.16. Expert Rev Respir Med. 2010. PMID: 20406080 Review.

3

Salmeterol and formoterol in partially reversible severe chronic obstructive pulmonary disease: a dose-response study.

Cazzola M, Matera MG, Santangelo G, Vinciguerra A, Rossi F, D'Amato G. Cazzola M, et al. Among authors: matera mg. Respir Med. 1995 May;89(5):357-62. doi: 10.1016/0954-6111(95)90008-x. Respir Med. 1995. PMID: 7638371 Free article. Clinical Trial.

4

A combination with clinical recommended dosages of salmeterol and ipratropium is not more effective than salmeterol alone in patients with chronic obstructive pulmonary disease.

Matera MG, Caputi M, Cazzola M. Matera MG, et al. Respir Med. 1996 Sep;90(8):497-9. doi: 10.1016/s0954-6111(96)90178-x. Respir Med. 1996. PMID: 8869445 Free article. Clinical Trial. No abstract available.

5

Effects of formoterol, salmeterol or oxitropium bromide on airway responses to salbutamol in COPD.

Cazzola M, Di Perna F, Noschese P, Vinciguerra A, Calderaro F, Girbino G, Matera MG. Cazzola M, et al. Among authors: matera mg. Eur Respir J. 1998 Jun;11(6):1337-41. doi: 10.1183/09031936.98.11061337. Eur Respir J. 1998. PMID: 9657576 Free article. Clinical Trial.

6

Early reversibility to salbutamol does not always predict bronchodilation after salmeterol in stable chronic obstructive pulmonary disease.

Cazzola M, Vinciguerra A, Di Perna F, Matera MG. Cazzola M, et al. Among authors: matera mg. Respir Med. 1998 Aug;92(8):1012-6. doi: 10.1016/s0954-6111(98)90347-x. Respir Med. 1998. PMID: 9893768 Free article. Clinical Trial.

7

Interrelationship between pharmacokinetics and pharmacodynamics in choosing the appropriate antibiotic and the dosage regimen for treating acute exacerbations of chronic bronchitis.

Cazzola M, Matera MG. Cazzola M, et al. Among authors: matera mg. Respir Med. 1998 Jul;92(7):895-901. doi: 10.1016/s0954-6111(98)90187-1. Respir Med. 1998. PMID: 10070561 Free article. Review. No abstract available.

8

Influence of higher than conventional doses of oxitropium bromide on formoterol-induced bronchodilation in COPD.

Cazzola M, Matera MG, Di Perna E, Califano C, D'Amato M, Mazzarella G. Cazzola M, et al. Among authors: matera mg. Respir Med. 1999 Dec;93(12):909-11. doi: 10.1016/s0954-6111(99)90058-6. Respir Med. 1999. PMID: 10653054 Free article. Clinical Trial.

9

Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary disease.

Cazzola M, Centanni S, Boveri B, Di Marco F, Santus P, Matera MG, Allegra L. Cazzola M, et al. Among authors: matera mg. Respiration. 2001;68(5):452-9. doi: 10.1159/000050550. Respiration. 2001. PMID: 11694805 Clinical Trial.

10

Formoterol Turbuhaler for as-needed therapy in patients with mild acute exacerbations of COPD.

Cazzola M, Di Perna F, D'Amato M, Califano C, Matera MG, D'Amato G. Cazzola M, et al. Among authors: matera mg. Respir Med. 2001 Nov;95(11):917-21. doi: 10.1053/rmed.2001.1172. Respir Med. 2001. PMID: 11716207 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

451 results

Search Page

Filters